These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Drug-induced porphyrin biosynthesis. IV. Investigation of the differences in response of isolated liver cells and the liver of the intact chick embryo to porphyria-inducing drugs. Racz WJ; Marks GS Biochem Pharmacol; 1972 Jan; 21(2):143-51. PubMed ID: 4645552 [No Abstract] [Full Text] [Related]
5. Experimental porphyria. I. The experimental porphyrias--a group of distinctive metabolic lesions. Sweeney GD; Janigan D; Mayman D; Lai H S Afr Med J; 1971 Sep; ():68-72. PubMed ID: 4113777 [No Abstract] [Full Text] [Related]
7. The role of substrates for glycine acyltransferase, and the role of sulfanilamide and acetate in the reversal of chemically-induced porphyria in the rat. Tephly TR; Condie LW; Piper WN Enzyme; 1973; 16(1):187-95. PubMed ID: 4791042 [No Abstract] [Full Text] [Related]
9. Inhibition of experimental porphyria with colchicine. Wysenbeek AJ; Schoenfeld N; Epstein O; Greenblat Y; Atsmon A Int J Biochem; 1985; 17(8):937-40. PubMed ID: 4043513 [TBL] [Abstract][Full Text] [Related]
10. Drugs and porphyria. De Matteis F S Afr Med J; 1971 Sep; ():126-33. PubMed ID: 5150265 [No Abstract] [Full Text] [Related]
11. Cimetidine suppresses chemically induced experimental hepatic porphyria. Marcus DL; Nadel H; Lew G; Freedman ML Am J Med Sci; 1990 Oct; 300(4):214-7. PubMed ID: 2248274 [TBL] [Abstract][Full Text] [Related]
12. Relation between the concentration of ATP and that of NADH and excess porphyrin formation in the liver of rats during experimental porphyria. Gajdos A; Gajdos-Török M Biochem Soc Symp; 1968; 28():45-7. PubMed ID: 4307929 [No Abstract] [Full Text] [Related]
13. Antilipaemic and antiporphyric activity of nicotinic acid in allylisopropylacetamide-treated rats. Pinelli A; Favalli L Biochim Biophys Acta; 1972 Sep; 279(2):316-9. PubMed ID: 5082502 [No Abstract] [Full Text] [Related]
14. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria. Blum I; Schoenfeld N; Atsmon A Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745 [No Abstract] [Full Text] [Related]
15. Tryptophan--niacin and tryptophan--serotonin pathways in weaning pigs with porphyria experimentally induced. Calandra P; Rampichini L; Severini M Acta Vitaminol Enzymol; 1972; 26(3):69-77. PubMed ID: 4678412 [No Abstract] [Full Text] [Related]
16. Polychlorinated biphenyls as inducers of hepatic porphyria in Japanese quail, with special reference to -aminolevulinic acid synthetase activity, fluorescence, and residues in the liver. Vos JG; Strik JJ; van Holsteÿn CW; Pennings JH Toxicol Appl Pharmacol; 1971 Oct; 20(2):232-40. PubMed ID: 5002436 [No Abstract] [Full Text] [Related]
17. Induction of acute renal porphyria in Japanese quail by Aroclor 1254. Miranda CL; Henderson MC; Wang JL; Nakaue HS; Buhler DR Biochem Pharmacol; 1986 Oct; 35(20):3637-9. PubMed ID: 3094542 [No Abstract] [Full Text] [Related]
18. Experimental porphyria. II. Drug-induced porphyrin biosynthesis. Creighton JM; Racz WJ; Tyrrell DL; Schneck DW; Marks GS S Afr Med J; 1971 Sep; ():79-81. PubMed ID: 5150298 [No Abstract] [Full Text] [Related]
19. Drug interactions in experimental hepatic porphyria: a model for the exacerbation by drugs of human variegate porphyria. De Matteis F Biochem J; 1972 Apr; 127(2):21P-22P. PubMed ID: 5076650 [No Abstract] [Full Text] [Related]
20. Influence of N-acetylcysteine on the hexachlorobenzene induced porphyria in rats. Lissner R; Brunner W; Bolsen K; Merk H; Goerz G Arzneimittelforschung; 1985; 35(4):713-5. PubMed ID: 4015737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]